UNSPSC 51111774: Vorinostat

This classification denotes a histone deacetylase inhibitor with the molecular formula C14H20N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 58IFB293JI, chemically known as saha, suberoylanilide hydroxamic acid but generally known as vorinostat, which bears US NIH Compound Identifier 5311. European Medicines Agency schedules Vorinostat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB23356.

UNSPSC 51111774 Vorinostat, a Commodity code, represents pharmaceutical products procured by state and local health agencies, though recent opportunities show limited direct activity under this specific code designation. State and local buyers under this code include county health departments, state pharmacy benefit programs, municipal fire and rescue divisions, and cooperative purchasing alliances spanning multiple states. The work involves sourcing prescription medications, over-the-counter pharmaceuticals, and medical supplies for health system operations, emergency response, and community health initiatives. Issuing bodies range from single jurisdictions managing immediate operational needs to multistate cooperative purchasing vehicles aggregating demand across member states and local agencies.

Recent solicitations spanning Florida, Texas, and Minnesota demonstrate the geographic spread and issuing-body diversity. Seminole County, Florida issued IFB 60459723LAS in June 2026 to procure 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Community Health Building, supporting a two-year initial term with one-year renewal option and fixed-fee pricing. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, seeking direct contracting models outside traditional pharmacy benefit managers and group purchasing organizations. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) administered by the Minnesota Department of Administration issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products with March 26, 2026 proposal deadline, requiring distribution through three authorized wholesalers and effective July 1, 2026. The City of Tampa's March 2026 IFB 26P00145 for medical and first aid supplies to the Fire Department Rescue Division—valued at $700,000—targeted certified Small Local Business Enterprises with a 5% bid discount, requiring delivery within five working days and medications with nine-month minimum shelf life remaining.